Article
Targeting host glycolysis as a strategy for antimalarial development
2020-10-10
Abstract excerpt
<h4>ABSTRACT</h4> Glycolysis controls cellular energy, redox balance, and biosynthesis. Antiglycolytic therapies are under investigation for treatment of obesity, cancer, aging, autoimmunity, and microbial diseases. Interrupting glycolysis is highly valued as a therapeutic strategy, because glycolytic disruption is generally tolerated in mammals. Unfortunately, anemia is a known dose-limiting side effect of these...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4ee9d407-3c3e-565a-8d6f-ef32e1231bff
- DOI
- 10.1101/2020.10.09.331728
